loadpatents
name:-0.11396789550781
name:-0.042062997817993
name:-0.0043890476226807
Dean; Nicholas M. Patent Filings

Dean; Nicholas M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dean; Nicholas M..The latest application filed is for "method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)".

Company Profile
4.41.101
  • Dean; Nicholas M. - Encinitas CA
  • Dean; Nicholas M. - Olivenhain CA
  • Dean; Nicholas M. - Carlsbad CA
  • Dean; Nicholas M. - Olivehain CA
  • Dean; Nicholas M. - Olivenheim CA
  • Dean, Nicholas M. - Olivenhein CA
  • Dean, Nicholas M - Olivenhain CA
  • Dean; Nicholas M. - Cardiff-by-the-Sea CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (ctgf)
App 20200190521 - Dean; Nicholas M. ;   et al.
2020-06-18
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20190323013 - Dean; Nicholas M. ;   et al.
2019-10-24
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20170335329 - Dean; Nicholas M. ;   et al.
2017-11-23
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
Grant 9,688,987 - Dean , et al. June 27, 2
2017-06-27
Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (ctgf)
App 20170022501 - Dean; Nicholas M. ;   et al.
2017-01-26
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20150376623 - Dean; Nicholas M. ;   et al.
2015-12-31
Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF)
Grant 9,173,894 - Dean , et al. November 3, 2
2015-11-03
Chimeric oligomeric compounds for modulation of splicing
Grant 9,157,081 - Bennett , et al. October 13, 2
2015-10-13
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
Grant 9,096,851 - Dean , et al. August 4, 2
2015-08-04
Method for reducing scarring during wound healing using antisense compounds directed to CTGF
Grant 8,946,172 - Mustoe , et al. February 3, 2
2015-02-03
Methods for inhibiting expression of connective tissue growth factor
Grant 8,772,260 - Dean , et al. July 8, 2
2014-07-08
Modification of MYD88 splicing using modified oligonucleotides
Grant 8,765,703 - Vickers , et al. July 1, 2
2014-07-01
Chimeric Oligomeric Compounds For Modulation Of Splicing
App 20140005374 - Bennett; C. Frank ;   et al.
2014-01-02
Chimeric oligomeric compounds for modulation of splicing
Grant 8,501,703 - Bennett , et al. August 6, 2
2013-08-06
Methods For Inhibiting Expression Of Connective Tissue Growth Factor
App 20130190382 - Dean; Nicholas M. ;   et al.
2013-07-25
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20130190380 - Dean; Nicholas M. ;   et al.
2013-07-25
Modulation Of Insulin Like Growth Factor I Receptor Expression
App 20130096176 - WRAIGHT; Christopher John ;   et al.
2013-04-18
Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (ctgf)
App 20120238937 - Dean; Nicholas M. ;   et al.
2012-09-20
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
Grant 8,252,762 - Dean , et al. August 28, 2
2012-08-28
Compositions and their uses directed to HBXIP
Grant 8,198,253 - Dobie , et al. June 12, 2
2012-06-12
Modulation Of Smad3 Expression
App 20110213011 - Dean; Nicholas M. ;   et al.
2011-09-01
Modulation Of Transforming Growth Factor-beta 1 Expression
App 20110172296 - Bennett; C. Frank ;   et al.
2011-07-14
Modification Of Myd88 Splicing Using Modified Oligonucleotides
App 20110092573 - Vickers; Timothy ;   et al.
2011-04-21
Method For Reducing Scarring During Wound Healing Using Antisense Compounds Directed To Ctgf
App 20110054004 - MUSTOE; THOMAS A. ;   et al.
2011-03-03
Chimeric Oligomeric Compounds For Modulation Of Splicing
App 20110039334 - Bennett; C. Frank ;   et al.
2011-02-17
Modification of MyD88 splicing using modified oligonucleotides
Grant 7,879,992 - Vickers , et al. February 1, 2
2011-02-01
Identification of novel pathways, genes and promoter motifs regulating adipogenesis
Grant 7,759,318 - Perera , et al. July 20, 2
2010-07-20
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20100130595 - Dean; Nicholas M. ;   et al.
2010-05-27
Compositions And Their Uses Directed To Hbxip
App 20100056607 - Dobie; Kenneth W. ;   et al.
2010-03-04
Efficient Reduction Of Target Rna's By Single- And Double-stranded Oligomeric Compounds
App 20100041047 - Vickers; Timothy ;   et al.
2010-02-18
Modulation Of Insulin Like Growth Factor I Receptor Expression
App 20090286849 - WRAIGHT; Christopher John ;   et al.
2009-11-19
Modulation Of Tudor-sn Expression
App 20090270491 - Dean; Nicholas M. ;   et al.
2009-10-29
Compositions And Their Uses Directed To Hsp27
App 20090264502 - Bennett; C. Frank ;   et al.
2009-10-22
Modulation of Tudor-SN expression
Grant 7,563,885 - Dean , et al. July 21, 2
2009-07-21
Modulation Of Insulin Like Growth Factor I Receptor Expression
App 20090111767 - WRAIGHT; Christoper J. ;   et al.
2009-04-30
Modulation of insulin like growth factor I receptor expression
Grant 7,468,356 - Wraight , et al. December 23, 2
2008-12-23
Modulation of Aurora B expression
Grant 7,375,212 - Dean , et al. May 20, 2
2008-05-20
Modulation Of Thyroid Hormone Receptor Interactor 3 Expression
App 20070265219 - Bennett; C. Frank ;   et al.
2007-11-15
Antisense Oligonucleotide Compositions And Methods For The Modulation Of Jnk Proteins
App 20070149472 - McKay; Robert ;   et al.
2007-06-28
Antisense modulation of bcl-x expression
Grant 7,148,204 - Bennett , et al. December 12, 2
2006-12-12
Modulation of insulin like growth factor i receptor expression
App 20060234239 - Wraight; Christopher John ;   et al.
2006-10-19
Modification of MYD88 splicing using modified oligonucleotides
App 20060172962 - Vickers; Timothy ;   et al.
2006-08-03
Antisense modulation of CD40 ligand expression
App 20060160758 - Bennett; C. Frank ;   et al.
2006-07-20
Modulation of SLC26A2 expression
App 20060154885 - Bennett; C. Frank ;   et al.
2006-07-13
Methods for blocking adipocyte differentiation and triglyceride accumulation with transcription factor dp-1 inhibitors
App 20060122131 - Marcusson; Eric G. ;   et al.
2006-06-08
Methods for blocking adipocyte differentiation and triglyceride accumulation with interleukin 12 p35 inhibitors
App 20060084061 - Marcusson; Eric G. ;   et al.
2006-04-20
Antisense modulation of MEKK4 expression
App 20060019920 - Bennett; C. Frank ;   et al.
2006-01-26
Compositions and their uses directed to bone growth modulators
App 20060003953 - Bennett; C. Frank ;   et al.
2006-01-05
Antisense oligonucleotides against thymidylate synthase
App 20050272683 - Koropatnick, Donald J. ;   et al.
2005-12-08
Modulation of Aurora B expression
App 20050267065 - Dean, Nicholas M. ;   et al.
2005-12-01
Antisense modulation of interleukin 12 P35 subunit expression
App 20050261228 - Bennett, C. Frank ;   et al.
2005-11-24
Modulation of kallikrein 6 expression
App 20050227939 - Bennett, C. Frank ;   et al.
2005-10-13
Antisense modulation of TFAP2C expression
App 20050227938 - Bennett, C. Frank ;   et al.
2005-10-13
Antisense modulation of thyroid hormone receptor interactor 6 expression
App 20050222073 - Bennett, C. Frank ;   et al.
2005-10-06
Antisense modulation of sterol regulatory element-binding protein-1 expression
App 20050215504 - Bennett, C. Frank ;   et al.
2005-09-29
Compositions and their uses directed to cell growth and maintenance proteins
App 20050186594 - Bennett, C. Frank ;   et al.
2005-08-25
Modulation of glucocorticoid receptor expression
App 20050164271 - Bhanot, Sanjay ;   et al.
2005-07-28
Compositions and their uses directed to metabolic proteins
App 20050164254 - Bennett, C. Frank ;   et al.
2005-07-28
Compositions and their uses directed to transferases
App 20050153925 - Bennett, C. Frank ;   et al.
2005-07-14
Antisense modulation of interferon gamma receptor 2
App 20050153924 - Bennett, C. Frank ;   et al.
2005-07-14
Antisense modulation of inducible nitric oxide synthase expression
App 20050113322 - Bennett, Frank C. ;   et al.
2005-05-26
Antisense modulation of FLIP-c expression
App 20040254137 - Ackermann, Elizabeth J. ;   et al.
2004-12-16
Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
Grant 6,809,193 - McKay , et al. October 26, 2
2004-10-26
Antisense modulation of novel anti-apoptotic bcl-2-related proteins
App 20040204380 - Ackermann, Elizabeth J. ;   et al.
2004-10-14
Modulation of insulin like growth factor I receptor expression
App 20040171149 - Wraight, Christopher J. ;   et al.
2004-09-02
Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression
App 20040171564 - Honkanen, Richard E. ;   et al.
2004-09-02
Modulation of thyroid hormone receptor interactor 3 expression
App 20040137441 - Bennett, C. Frank ;   et al.
2004-07-15
Efficient reduction of target RNA's by single-and double-stranded oligomeric compounds
App 20040137471 - Vickers, Timothy ;   et al.
2004-07-15
Antisense modulation of interleukin-5 signal transduction
App 20040121376 - Dean, Nicholas M. ;   et al.
2004-06-24
Modulation of MAGE-D1 expression
App 20040110702 - Bennett, C. Frank ;   et al.
2004-06-10
Modulation of MALT1 expression
App 20040110145 - Bennett, C. Frank ;   et al.
2004-06-10
Modulation of EMAP-II expression
App 20040110144 - Bennett, C. Frank ;   et al.
2004-06-10
Modulation of AP-2 alpha expression
App 20040109848 - Bennett, C. Frank ;   et al.
2004-06-10
Modulation of jagged 1 expression
App 20040102401 - Dean, Nicholas M. ;   et al.
2004-05-27
Modulation of heat shock protein 90-alpha expression
App 20040102393 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of Gankyrin expression
App 20040102391 - Dean, Nicholas M. ;   et al.
2004-05-27
Modulation of PPM1B expression
App 20040102397 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of huntingtin interacting protein 2 expression
App 20040102394 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of hepatocyte growth factor receptor expression
App 20040102622 - Dean, Nicholas M. ;   et al.
2004-05-27
Modulation of squalene synthase expression
App 20040102405 - Freier, Susan M. ;   et al.
2004-05-27
Modulation of BCL2-associated athanogene 5 expression
App 20040102396 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of BCL2-associated athanogene expression
App 20040101854 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of selenoprotein W expression
App 20040101849 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of c-src tyrosine kinase expression
App 20040101850 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of ADAM15 expression
App 20040102392 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of UBE2G1 expression
App 20040102400 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of fibrillarin expression
App 20040102403 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of CGG triplet repeat binding protein 1 expression
App 20040101852 - Bennett, C. Frank ;   et al.
2004-05-27
Modulation of jumonji expression
App 20040097440 - Bennett, C. Frank ;   et al.
2004-05-20
Modulation of mitogen-activated protein kinase kinase kinase 11 expression
App 20040092464 - Bennett, C. Frank ;   et al.
2004-05-13
Modulation of ADAM9 expression
App 20040092466 - Bennett, C. Frank ;   et al.
2004-05-13
Modulation of endothelial differentiation gene 2 expression
App 20040092462 - Bennett, C. Frank ;   et al.
2004-05-13
Antisense modulation of PI3K P85 Expression
App 20040077580 - Monia, Brett P. ;   et al.
2004-04-22
Antisense modulation of transforming growth factor-beta expression
App 20040063655 - Dean, Nicholas M. ;   et al.
2004-04-01
Antisense modulation of Fas mediated signaling
App 20040033979 - Dean, Nicholas M. ;   et al.
2004-02-19
Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
App 20040029823 - McKay, Robert ;   et al.
2004-02-12
Antisense modulation of phosphotyrosyl phosphatase activator expression
App 20040023906 - Dean, Nicholas M. ;   et al.
2004-02-05
Antisense modulation of PPP2R1A expression
App 20040023381 - Bennett, C. Frank ;   et al.
2004-02-05
Antisense modulation of PPP3CB expression
App 20040023382 - Dean, Nicholas M. ;   et al.
2004-02-05
Antisense modulation of HMG-CoA reductase expression
App 20040006031 - Dean, Nicholas M. ;   et al.
2004-01-08
Antisense modulation of geranylgeranyl diphosphate synthase 1 expression
App 20040005570 - Dean, Nicholas M. ;   et al.
2004-01-08
Antisense modulation of cell division cycle 2 expression
App 20040006029 - Dean, Nicholas M. ;   et al.
2004-01-08
Antisense modulation of cyclin-dependent kinase 4 expression
App 20040005567 - Dean, Nicholas M. ;   et al.
2004-01-08
Antisense modulation of Fas mediated signaling
Grant 6,653,133 - Dean , et al. November 25, 2
2003-11-25
Antisense oligonucleotide compositions and methods for the modulation of activating protein 1
App 20030194738 - Dean, Nicholas M. ;   et al.
2003-10-16
Antisense modulation of bcl-x expression
App 20030191300 - Bennett, C. Frank ;   et al.
2003-10-09
Oligonucleotide inhibition of protein kinase C
App 20030148989 - Bennett, C. Frank ;   et al.
2003-08-07
Antisense oligonucleotide inhibition of human serine/threonine protein phosphatase gene expression
Grant 6,599,742 - Honkanen , et al. July 29, 2
2003-07-29
Antisense modulation of daxx expression
App 20030083297 - Dean, Nicholas M ;   et al.
2003-05-01
Inhibition Of Stress Activated Protein Kinase (sapk) Pathway And Sensitization Of Cells To Cancer Therapies
App 20030060433 - MERCOLA, DANIEL A. ;   et al.
2003-03-27
Antisense modulation of transforming growth factor-beta expression
App 20030050265 - Dean, Nicholas M. ;   et al.
2003-03-13
Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
App 20030004120 - McKay, Robert ;   et al.
2003-01-02
Antisense modulation of interleukin-5 signal transduction
App 20020128216 - Dean, Nicholas M. ;   et al.
2002-09-12
Antisense inhibition of transforming growth factor-.beta. expression
Grant 6,436,909 - Dean , et al. August 20, 2
2002-08-20
Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression
App 20020082415 - Honkanen, Richard E. ;   et al.
2002-06-27
Antisense oligonucleotide compositions and methods for the modulation of activating protein 1
App 20020039741 - Dean, Nicholas M. ;   et al.
2002-04-04
Antisense inhibition of HPK/GCK-like kinase expression
Grant 6,346,416 - Dean , et al. February 12, 2
2002-02-12
Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate .beta.I, .beta.II, .gamma., .delta., .EPSILON., .zeta. and .eta. isoforms of human protein kinase C
Grant 6,339,066 - Bennett , et al. January 15, 2
2002-01-15
Antisense modulation of Fas mediated signaling
App 20020004490 - Dean, Nicholas M. ;   et al.
2002-01-10
Antisense modulation of bcl-x expression
App 20010007025 - Bennett, C. Frank ;   et al.
2001-07-05
Antisense modulation of bcl-x expression
Grant 6,214,986 - Bennett , et al. April 10, 2
2001-04-10
Antisense inhibition of Fas mediated signaling
Grant 6,204,055 - Dean , et al. March 20, 2
2001-03-20
Antisense modulation of BCL-X expression
Grant 6,172,216 - Bennett , et al. January 9, 2
2001-01-09
Oligonucleotide modulation of protein kinase C
Grant 6,015,892 - Bennett , et al. January 18, 2
2000-01-18
Antisense oligonucleotide modulation of MDR P-glycoprotein gene expression
Grant 6,001,991 - Dean , et al. December 14, 1
1999-12-14
Antisense modulation of novel anti-apoptotic bcl-2-related proteins
Grant 6,001,992 - Ackermann , et al. December 14, 1
1999-12-14
Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
Grant 5,985,558 - Dean , et al. November 16, 1
1999-11-16
Methoxyethoxy oligonucleotides for modulation of protein kinase C expression
Grant 5,948,898 - Dean , et al. September 7, 1
1999-09-07
Antisense oligonucleotides to human serine/threonine protein phosphatase genes
Grant 5,948,902 - Honkanen , et al. September 7, 1
1999-09-07
Antisense oligonucleotides against JNK
Grant 5,877,309 - McKay , et al. March 2, 1
1999-03-02
Antisense oligonucleotide modulation of multidrug resistance-associated protein
Grant 5,801,154 - Baracchini , et al. September 1, 1
1998-09-01
Combination for treatment of proliferative diseases
Grant 5,744,460 - Muller , et al. April 28, 1
1998-04-28
Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
Grant 5,681,747 - Boggs , et al. October 28, 1
1997-10-28
Company Registrations
SEC0001600468Dean Nicholas M.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed